SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMAT - ultrafast tomography for coronary artery disease

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: stock bull who wrote (2557)6/21/1998 12:12:00 PM
From: Bruce Rozenblit  Read Replies (2) of 3725
 
The Seimens deal sucked big time. Every machine sold through them was sold at the cost of production, i.e. NO PROFIT. Those days are gone. Secondly, Seimens Medical System's has been all screwed up. They have no focus and have been playing musical chairs at top level positions. Imatron was an occasional pastime activity for them.

I'm sure GE will get a large enough cut to make it worth the trouble but the contracts are written to Imatron, so that means GE has to wait for Imat to write the commission check, a good position to be in.

Image means everything. GE has the best and Imat will need years to build one. Its the old crap, "Well they are a small company and may be out of business next year". I fight that all of the time with my small firm. The association with GE gives them instant credibility in the marketplace. Now if we can figure out a way to get GE to buy HeartScan. Maybe they can pay GE with HeartScan stock and just walk away from it!

One more thought. GE's credit branch makes a lot of money lending money for all kinds of stuff. This could be another source of low risk, long term loans to feed their money maker. That in itself is a justafyable reason for the linkage.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext